These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 34926323)
1. Comparative Analysis of Salivary Mycobiome Diversity in Human Immunodeficiency Virus-Infected Patients. Chang S; Guo H; Li J; Ji Y; Jiang H; Ruan L; Du M Front Cell Infect Microbiol; 2021; 11():781246. PubMed ID: 34926323 [TBL] [Abstract][Full Text] [Related]
2. Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses. Fidel PL; Thompson ZA; Lilly EA; Granada C; Treas K; Dubois KR; Cook L; Hashmi SB; Lisko DJ; Mukherjee C; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Beall CJ mBio; 2021 Mar; 12(2):. PubMed ID: 33758093 [TBL] [Abstract][Full Text] [Related]
3. Analysis of Salivary Mycobiome in a Cohort of Oral Squamous Cell Carcinoma Patients From Sudan Identifies Higher Salivary Carriage of Mohamed N; Litlekalsøy J; Ahmed IA; Martinsen EMH; Furriol J; Javier-Lopez R; Elsheikh M; Gaafar NM; Morgado L; Mundra S; Johannessen AC; Osman TA; Nginamau ES; Suleiman A; Costea DE Front Cell Infect Microbiol; 2021; 11():673465. PubMed ID: 34712619 [TBL] [Abstract][Full Text] [Related]
5. Altered Salivary Microbiome in the Early Stage of HIV Infections among Young Chinese Men Who Have Sex with Men (MSM). Li J; Chang S; Guo H; Ji Y; Jiang H; Ruan L; Du M Pathogens; 2020 Nov; 9(11):. PubMed ID: 33228000 [TBL] [Abstract][Full Text] [Related]
6. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy. Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712 [TBL] [Abstract][Full Text] [Related]
7. Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated with Aging, HIV Load, CD4 Count, and Antiretroviral Therapy. Lewy T; Hong BY; Weiser B; Burger H; Tremain A; Weinstock G; Anastos K; George MD AIDS Res Hum Retroviruses; 2019 Mar; 35(3):276-286. PubMed ID: 29808701 [TBL] [Abstract][Full Text] [Related]
8. The palatine tonsil bacteriome, but not the mycobiome, is altered in HIV infection. Fukui Y; Aoki K; Ishii Y; Tateda K BMC Microbiol; 2018 Oct; 18(1):127. PubMed ID: 30290791 [TBL] [Abstract][Full Text] [Related]
9. Neglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity. Li S; Yang X; Moog C; Wu H; Su B; Zhang T Front Immunol; 2022; 13():1015775. PubMed ID: 36439143 [TBL] [Abstract][Full Text] [Related]
10. Salivary microbial diversity at different stages of human immunodeficiency virus infection. Guo Y; Xia W; Wei F; Feng W; Duan J; Sun X; Yu Y; Wang Y; Zhang B; Cao J; Li W; Dong H; Guo S; Zhang F; Huang X; Sun Z Microb Pathog; 2021 Jun; 155():104913. PubMed ID: 33915204 [TBL] [Abstract][Full Text] [Related]
11. Oral Microbiota Is Associated With Immune Recovery in Human Immunodeficiency Virus-Infected Individuals. Xie Y; Sun J; Hu C; Ruan B; Zhu B Front Microbiol; 2021; 12():794746. PubMed ID: 34956162 [TBL] [Abstract][Full Text] [Related]
12. Salivary human beta-defensins affected by oral Candida status in Chinese HIV/AIDS patients undergoing ART. Liu Z; Yong X; Jiang L; Zhang L; Lin X; Liu W; Peng Y; Tao R Oral Dis; 2018 Sep; 24(6):964-971. PubMed ID: 29498794 [TBL] [Abstract][Full Text] [Related]
13. Keystone salivary mycobiome in postpartum period in health and disease conditions. Khadija B; Imran M; Faryal R J Mycol Med; 2021 Mar; 31(1):101101. PubMed ID: 33321299 [TBL] [Abstract][Full Text] [Related]
14. Independent Effects of HIV and Antiretroviral Therapy on the Oral Microbiome Identified by Multivariate Analyses. Beall CJ; Lilly EA; Granada C; Treas K; Dubois KR; Hashmi SB; Vazquez JA; Hagensee ME; Griffen AL; Leys EJ; Fidel PL mBio; 2023 Jun; 14(3):e0040923. PubMed ID: 37071004 [TBL] [Abstract][Full Text] [Related]
15. Comparison of salivary total protein and electrolyte profile in HIV patients with and without antiretroviral therapy. Mahajan PG; Kheur SM; Mahajan GD; Kheur M; Raj AT; Patil S; Awan KH Dis Mon; 2021 Sep; 67(9):101165. PubMed ID: 33640174 [TBL] [Abstract][Full Text] [Related]
16. Characterization of intestinal fungal community diversity in people living with HIV/AIDS (PLWHA). Meng P; Zhang G; Ma X; Ding X; Song X; Dang S; Yang R; Xu L AIDS Res Ther; 2024 Feb; 21(1):10. PubMed ID: 38350942 [TBL] [Abstract][Full Text] [Related]
17. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy. Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO mBio; 2021 Mar; 12(2):. PubMed ID: 33688002 [TBL] [Abstract][Full Text] [Related]
18. Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections. Sagoe KW; Duedu KO; Ziga F; Agyei AA; Adiku TK; Lartey M; Mingle JA; Arens M Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):38. PubMed ID: 27251610 [TBL] [Abstract][Full Text] [Related]
19. High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Miller CS; Berger JR; Mootoor Y; Avdiushko SA; Zhu H; Kryscio RJ J Clin Microbiol; 2006 Jul; 44(7):2409-15. PubMed ID: 16825357 [TBL] [Abstract][Full Text] [Related]
20. Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration. Watanabe D; Ibe S; Uehira T; Minami R; Sasakawa A; Yajima K; Yonemoto H; Bando H; Ogawa Y; Taniguchi T; Kasai D; Nishida Y; Yamamoto M; Kaneda T; Shirasaka T BMC Infect Dis; 2011 May; 11():146. PubMed ID: 21605468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]